Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Autophagic Cell Survival-to-Death Switch Induced by Cisplatin and Zn(II) Dual-Loaded Dispersity-Tunable Zwitterionic Hybrid Polyion Nanocomplex.

ACS applied materials & interfaces·2025

Same author

RSK2-mediated cGAS phosphorylation induces cGAS chromatin-incorporation-mediated cell transformation and cancer cell colony growth.

Cell death discovery·2024

Same author

Beyond nanoparticle-based oral drug delivery: transporter-mediated absorption and disease targeting.

Biomaterials science·2024

Same author

ELK3 destabilization by speckle-type POZ protein suppresses prostate cancer progression and docetaxel resistance.

Cell death & disease·2024

Same author

Beyond Nanoparticle-Based Intracellular Drug Delivery: Cytosol/Organelle-Targeted Drug Release and Therapeutic Synergism.

Macromolecular bioscience·2024

Same author

Toxicokinetics of β-Amanitin in Mice and In Vitro Drug-Drug Interaction Potential.

Pharmaceutics·2022

Same journal

Light-Curable Methacrylated Carboxymethyl Chitosan Hydrogel Incorporating Bone Morphogenic Protein-2-Immobilized Bioactive Glass for Spinal Bone Regeneration.

Biomaterials research·2026

Same journal

Nanoparticle-Based Antigen Delivery: Advancing Immunization Strategies against Infectious Pathogens.

Biomaterials research·2026

Same journal

Targeted Sirtuin 3 Activation by Biomimetic Black Phosphorus Nanosheets Mitigates Sepsis-Induced Acute Kidney Injury through Yeast Mitochondrial Escape 1-Like 1 Deacetylation.

Biomaterials research·2026

Same journal

A Hybrid Mesenchymal-Stem-Cell-Derived Decellularized Matrix Scaffold Supports Bone Repair and Vascular Perfusion in Steroid-Associated Osteonecrosis.

Biomaterials research·2026

Same journal

Biomimetic Nanogels Programmed for Irreversible-Electroporation-Primed Tumor Microenvironments to Elicit Durable Antitumor Immunity.

Biomaterials research·2026

Same journal

Restoring Zinc Homeostasis via a Bimetallic Nanozyme to Amplify Ferroptosis and Antitumor Immunity for Prostate Cancer Treatment.

Biomaterials research·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 12, 2026

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Mitochondria-targeting theranostics.

Han Chang Kang¹

¹Department of Pharmacy, College of Pharmacy, The Catholic University of Korea, 43 Jibong-ro, Wonmi-gu, Bucheon-si, Gyeonggi-do 14662 Republic of Korea.

Biomaterials Research

|November 21, 2018

Summary

This summary is machine-generated.

Mitochondria-targeting theranostics offer enhanced drug delivery for diseases. This review explores current chemicals, conjugates, and nanosystems, discussing their potential and alternatives for improved therapeutic outcomes.

Keywords:

Diagnostics Drug delivery Mitochondria-targeting Subcellular targeting Theranostics

More Related Videos

Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates

Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates

Published on: August 6, 2021

Molecular Imaging to Target Transplanted Muscle Progenitor Cells

Molecular Imaging to Target Transplanted Muscle Progenitor Cells

Published on: March 27, 2013

Related Experiment Videos

Last Updated: Jan 12, 2026

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates

Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates

Published on: August 6, 2021

Molecular Imaging to Target Transplanted Muscle Progenitor Cells

Molecular Imaging to Target Transplanted Muscle Progenitor Cells

Published on: March 27, 2013

Area of Science:

Biomedical Engineering
Nanotechnology
Pharmacology

Background:

Subcellular organelle-targeting theranostics are gaining interest for improved drug delivery and disease diagnosis.
Mitochondria are key organelles, making them significant targets for theranostic applications.
Theranostics combine therapeutics and diagnostics for precise disease treatment.

Purpose of the Study:

To review current advancements in mitochondria-targeting theranostics.
To summarize existing mitochondria-targeting chemicals, conjugates, and nanosystems.
To discuss challenges and future directions in the field.

Main Methods:

Literature review of current studies on mitochondria-targeting theranostics.
Categorization of mitochondria-targeting moieties and theranostic types.
Summary of chemical, conjugate, and nanosystem-based theranostics.

Main Results:

Overview of various mitochondria-targeting theranostic approaches.
Identification of key components and strategies in current theranostics.
Analysis of the efficacy and limitations of existing systems.

Conclusions:

Current mitochondria-targeting theranostic chemicals, conjugates, and nanosystems face challenges.
Potential alternatives and future research directions are discussed.
Optimizing mitochondria-targeting theranostics is crucial for maximizing therapeutic effects and minimizing side effects.